JB
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JB Accepts, published online ahead of print on 21 November 2008
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Davidsen, J. M.
Right arrow Articles by Townsend, C. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davidsen, J. M.
Right arrow Articles by Townsend, C. A.

 Previous Article  |  Next Article 

J. Bacteriol. doi:10.1128/JB.01833-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Identification and Characterization of NocR as a Positive Transcriptional Regulator of the {beta}-Lactam Nocardicin A in Nocardia uniformis

Jeanne M. Davidsen and Craig A. Townsend*

Department of Chemistry, Johns Hopkins University, Baltimore, Maryland, 21218, USA

* To whom correspondence should be addressed. Email: ctownsend{at}jhu.edu.


   Abstract

Nocardicin A is a monocyclic {beta}-lactam isolated from the actinomycete Nocardia uniformis, which shows moderate activity against a broad spectrum of Gram-negative bacteria. Within the biosynthetic gene cluster of nocardicin A, nocR encodes a 583 amino acid protein with high similarity to a class of transcriptional regulators known as Streptomyces Antibiotic Regulatory Proteins, SARPs. Insertional inactivation of this gene resulted in a mutant showing morphology and growth characteristics similar to the wild-type, but one that did not produce detectable levels of nocardicin A or the early precursor p-hydroxybenzoyl formate. Similar disruption of nocD, nocE, and nocO yielded mutants that maintain production of nocardicin A at a level similar to the wild-type strain. In trans complementation of the nocR::apr mutant partially restored the wild-type phenotype. Transcriptional analysis of the nocR::apr mutant using RT-PCR found an absence of mRNA transcripts for the early-stage nocardicin A biosynthetic genes. In addition, transcription of the genes responsible for the biosynthesis of the non-proteinogenic p-hydroxyphenylglycine (pHPG) precursor was attenuated on the nocR disruption mutant. NocR was heterologously expressed and purified from E. coli as an N-terminal MBP-tagged fusion protein. DNA-binding assays demonstrate that NocR is a DNA binding protein, targeting the 126 bp intergenic region between nocF and nocA. Within this intergenic region is the likely binding motif, a direct hexameric repeat, TGATAA, with a 5 bp spacer. These experiments establish NocR as a positive transcriptional regulator of the nocardicin A biosynthetic pathway, coordinating the initial steps of nocardicin A biosynthesis to the production of its pHPG precursor.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Appl. Environ. Microbiol. Infect. Immun. Eukaryot. Cell
Mol. Cell. Biol. J. Virol. Microbiol. Mol. Biol. Rev.
ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.